Delivery Order SPE2DB22D1106-SPE2DB25FEJA7
Award Date
4/16/25
Potential Completion Date
4/17/25
Potential Value
$4.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,551.60, is a delivery order for OVIDREL 250 MCG/0.5 ML SYRG 0.5ML medical supplies. The contract has an ultimate completion date of March 31, 2025 and is a firm fixed price agreement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,529.97 firm fixed-price contract is for the supply of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a medical product used in healthcare settings. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution services company. The $1,789.07 firm fixed price delivery order is for 4563830856, described as OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, to be delivered by March 4, 2024. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML medical supplies. The contract, valued at $2,100.90, was awarded by the Defense Logistics Agency (DLA) with a completion date of March 18, 2025. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,456.60, is for the supply of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a medical product. The contract is not set aside and is awarded as part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This IDC provides a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,242.80, is for the supply of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 12, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award, with the ID SPE2DB22D1106|SPE2DB24FFKK9, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a pharmaceutical product, with a ceiling value of $4,066.82 and a completion date of September 3, 2024. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation. Amerisourcebergen Drug Corp, a...
This federal contract award is for the delivery of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $6,002.18 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 12, 2024. The contract has an ultimate completion date of December 13, 2024 and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide OVIDREL 250 MCG/0.5 ML SYRG 0.5ML pharmaceutical supplies. The contract has a potential value of $3,171.60 and a completion date of February 2, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is issued under Amerisourcebergen Drug Corp's indefinite...
This federal contract award was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,839.00 firm fixed-price delivery order is for the supply of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a pharmaceutical product, with a completion date of June 21, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...